Gene:
GRM7
glutamate receptor, metabotropic 7

PharmGKB contains no prescribing info for this . Contact us to report known genotype-based dosing guidelines, or if you are interested in developing guidelines.

PharmGKB has no annotated drug labels with pharmacogenomic information for this . If you know of a drug label with PGx, send us a message.

PharmGKB contains no Clinical Variants that meet the highest level of criteria.

To see more Clinical Variants with lower levels of criteria, click the button at the bottom of the table.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

The table below contains information about pharmacogenomic variants on PharmGKB. Please follow the link in the "Variant" column for more information about a particular variant. Each link in the "Variant" column leads to the corresponding PharmGKB Variant Page. The Variant Page contains summary data, including PharmGKB manually curated information about variant-drug pairs based on individual PubMed publications. The PMIDs for these PubMed publications can be found on the Variant Page.

The tags in the first column of the table indicate what type of information can be found on the corresponding Variant Page on the appropriate tab.

Links in the "Drugs" column lead to PharmGKB Drug Pages.

List of all variant annotations for GRM7

Variant?
(147)
Alternate Names ? Chemicals ? Alleles ?
(+ chr strand)
Function ? Amino Acid?
Translation
rs2069062 NC_000003.11:g.7034549G>C, NC_000003.12:g.6992862G>C, NG_029781.1:g.136748G>C, NM_000844.3:c.519+130955G>C, NM_181874.2:c.519+130955G>C, XM_005265095.1:c.519+130955G>C, XR_940422.1:n.811+130955G>C, rs4686105, rs56453606, rs58638926
G > C
SNP
Alleles, Functions, and Amino Acid Translations are all sourced from dbSNP 147

Overview

Alternate Names:  protein phosphatase 1, regulatory subunit 87
Alternate Symbols:  GLUR7; GPRC1G; MGLUR7; PPP1R87; mGlu7
PharmGKB Accession Id: PA28996

Details

Cytogenetic Location: chr3 : p26.1 - p25.1
GP mRNA Boundary: chr3 : 6902802 - 7783218
GP Gene Boundary: chr3 : 6892802 - 7786218
Strand: plus

Visualization

UCSC has a Genome Browser that you can use to view PharmGKB annotations for this gene in context with many other sources of information.

View on UCSC Browser
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.
No related genes are available

Curated Information ?

Evidence Drug
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
risperidone

Curated Information ?

Evidence Disease
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Schizophrenia

Publications related to GRM7: 3

No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes. Translational psychiatry. 2016. Stevenson J M, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2008. Mick Eric, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science (New York, N.Y.). 2008. Walsh Tom, et al. PubMed

LinkOuts

NCBI Gene:
2917
OMIM:
604101
UCSC Genome Browser:
NM_000844
RefSeq RNA:
NM_000844
NM_181874
RefSeq Protein:
NP_000835
NP_870989
RefSeq DNA:
NT_022517
HuGE:
GRM7
Comparative Toxicogenomics Database:
2917
ModBase:
Q14831
IUPHAR Receptor:
mGlu7 (295)
HGNC:
4599

Common Searches